EUVIMEDEUVIMED entdecken
Crossref

Palmitoylation licenses RIPK1 kinase activity and cytotoxicity in the TNF pathway

Na Zhang, Jianping Liu, Rui Guo, Lingjie Yan, Yuanxin Yang, Chen Shi, Mengmeng Zhang, Bing Shan, Wanjin Li, Jinyang Gu, Daichao Xu

Molecular Cell · 2024-11 · 84 (22) · 4419-4435.e10

DOI: 10.1016/j.molcel.2024.10.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Cell, 2024-11. Verfasst von Na Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 201210, Ch…. Hauptthemen laut MEDLINE: Lipoylation, Receptor-Interacting Protein Serine-Threonine Kinases, Ubiquitination, Tumor Necrosis Factor-alpha. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 79 Literaturangaben. Gefördert von: National Science Fund for Distinguished Young Scholars, National Natural Science Foundation of China, Shanghai Science and Technology Development Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor necrosis factor (TNF)-induced receptor-interacting serine/threonine protein kinase 1 (RIPK1)-mediated cell death, including apoptosis and necroptosis, is increasingly recognized as a major driver of inflammatory diseases. Cell death checkpoints normally suppress RIPK1 kinase to safeguard the organism from its detrimental consequences. However, the mechanisms licensing RIPK1 kinase activity when a protective checkpoint is disabled remain unclear. Here, we identified S-palmitoylation as a licensing modification for RIPK1 kinase. TNF induces RIPK1 palmitoylation, mediated by DHHC5 and dependent on K63-linked ubiquitination of RIPK1, which enhances RIPK1 kinase activity by promoting the homo-interaction of its kinase domain and promotes cell death upon cell death checkpoint blockade. Furthermore, DHHC5 is amplified by fatty acid in the livers of mice with metabolic dysfunction-associated steatohepatitis, contributing to increased RIPK1 cytotoxicity observed in this condition. Our findings reveal that ubiquitination-dependent palmitoylation licenses RIPK1 kinase activity to induce downstream cell death signaling and suggest RIPK1 palmitoylation as a feasible target for inflammatory diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LipoylationReceptor-Interacting Protein Serine-Threonine KinasesUbiquitinationTumor Necrosis Factor-alphaSignal TransductionAnimalsHumansHEK293 CellsApoptosisFatty LiverMiceMice, Inbred C57BLLiverMice, KnockoutNecroptosisMale

Stichwörter der Autor:innen

DHHC5RIPK1TNF pathwayapoptosismetabolic dysfunction-associated steatohepatitisnecroptosispalmitoyl acyltransferasepalmitoylation

Substanzen

Receptor-Interacting Protein Serine-Threonine KinasesTumor Necrosis Factor-alphaRipk1 protein, mouseRIPK1 protein, human

Autor:innen und Institutionen

  • Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 201210, China; University of Chinese Academy of Sciences, Beijing 101408, China.
  • Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 201210, China.
  • Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 201210, China; Shanghai Key Laborshiatory of Aging Studies, Shanghai 201210, Chi…
  • Center for Liver Transplantation, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, Hubei, China; Key Laboratory of Organ Transplantation, Ministry of Education, NHC Ke…

Förderung

  • National Science Fund for Distinguished Young Scholars
  • National Natural Science Foundation of China
  • Shanghai Science and Technology Development Foundation
  • Chinese Academy of Sciences
  • Fudan University

Zitieren

APA

Zhang, N., Liu, J., Guo, R., Yan, L., Yang, Y., Shi, C., Zhang, M., Shan, B., Li, W., Gu, J., & Xu, D. (2024). Palmitoylation licenses RIPK1 kinase activity and cytotoxicity in the TNF pathway. Molecular Cell, 84(22), 4419-4435.e10. https://doi.org/10.1016/j.molcel.2024.10.002

Vancouver

Zhang N, Liu J, Guo R, Yan L, Yang Y, Shi C, et al. Palmitoylation licenses RIPK1 kinase activity and cytotoxicity in the TNF pathway. Molecular Cell. 2024;84(22):4419-4435.e10. doi:10.1016/j.molcel.2024.10.002

BibTeX
@article{Zhang2024,
  author = {Zhang, Na and Liu, Jianping and Guo, Rui and Yan, Lingjie and Yang, Yuanxin and Shi, Chen and Zhang, Mengmeng and Shan, Bing and Li, Wanjin and Gu, Jinyang and Xu, Daichao},
  title = {Palmitoylation licenses RIPK1 kinase activity and cytotoxicity in the TNF pathway},
  journal = {Molecular Cell},
  year = {2024},
  volume = {84},
  number = {22},
  pages = {4419--4435.e10},
  doi = {10.1016/j.molcel.2024.10.002}
}
Kostenlos starten →